Previous Close | 0.6390 |
Open | 0.6200 |
Bid | 0.6110 x 100 |
Ask | 0.6298 x 100 |
Day's Range | 0.6000 - 0.6390 |
52 Week Range | 0.3300 - 2.6550 |
Volume | |
Avg. Volume | 143,725 |
Market Cap | 46.181M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
TOI reports a robust revenue increase and strategic expansions, counterbalanced by margin pressures and operational losses in the first quarter of 2024.
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call Transcript March 27, 2024 The Oncology Institute, Inc. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.11. TOI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, […]
Oncology Institute ( NASDAQ:TOI ) Full Year 2023 Results Key Financial Results Revenue: US$324.2m (up 28% from FY...